Table 1.
Summary of data reported in published reports on weight loss and cachexia in COVID‐19 patients
| Parameters | Pironi et al. 11 (n = 268) | Di Filippo et al. 6 (n = 213) | Allard et al. 10 (n = 108) |
|---|---|---|---|
| Date published | August 2020 | October 2020 | November 2020 |
| Origin of data | Bologna, Italy | Milan, Italy | Bobigny, France |
| Patient inclusion | Retrospective | Retrospective | Retrospective |
| Time of assessment | During treatment of COVID‐19 (in hospital) | After COVID‐19 in remission (outpatients) | At time of hospital admission for COVID‐19 |
| Age (years), mean ± SD or median (IQR) | 74 (63–84) | 59 (50–68) | 62 ± 16 |
| Female, n (%) | 121 (45) | 71 (33) | 44 (41) |
| BMI (kg/m2), mean ± SD or median (IQR) | 25.1 (22.0–27.8) | 27.1 (24.7–31.0) | 28.8 ± 6.2 |
| Number of hospitalized patients, n (%) | 268 (100) | 156 (73) a | 108 (100) |
| Intensive care unit treatment, n (%) | 46 (17) | 5 (3) | 14 (13) |
| Intermediate care unit treatment b | 183 (68) | NA | NA |
| Severe COVID‐19 c , n (%) | NA | NA | 34 (32) |
| Mild/moderate COVID‐19, n (%) | NA | NA | 74 (69) |
| Weight loss ≥5% during COVID‐19 or in the last month, n (%) | 65 (52) d | 61 (29) | 40 (37) |
| Observed weight loss ≥10% in last 6 months, n (%) | NA | NA | 10 (10) |
a
Previously hospitalized patients.
b
Intermediate care unit treatment or care in ‘sub‐intensive care’ unit as described by authors.
c
Defined as nasal oxygen ≥6 L/min.
d
Data regarding weight loss were available in 125 of 268 patients.